De novo Drug Design – Ye olde Scoring Problem Revisited

Molecular Informatics

Volumn 36, Issue 1, 2017, Pages

  Schneider, Gisbert ^a   Funatsu, Kimito ^b   Okuno, Yasushi ^c   Winkler, Dave ^d  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF TOKYO   (Japan)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d CSIRO   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DESIGN;

CYCLOOXYGENASE 2 INHIBITOR; LIGAND; POLYPEPTIDE ANTIBIOTIC AGENT;

ALGORITHM; COMPUTER AIDED DESIGN; COMPUTER MODEL; DRUG DESIGN; DRUG SCREENING; EDITORIAL; HEURISTICS; PRIORITY JOURNAL; SCORING SYSTEM; STRUCTURE ACTIVITY RELATION; VIRTUAL REALITY; ORGANIZATION;

CONGRESSES AS TOPIC; DRUG DESIGN;

EID: 85010645161     PISSN: 18681743     EISSN: 18681751     Source Type: Journal    
DOI: 10.1002/minf.201681031     Document Type: Editorial

References (21)

1. G. Schneider, U. Fechner, Nat. Rev. Drug Discov. 2005, 4, 649–663.
2. G. Schneider (ed) De Novo Molecular Design. Wiley-VCH, Weinheim, 2013.
3. P. Schneider, G. Schneider, J. Med. Chem. 2016, 59, 4077–4086.
4. G. R. Bickerton, G. V. Paolini, J. Besnard, S. Muresan, A. L. Hopkins, Nat. Chem. 2012, 4, 90–98;
5. W. P. Walters, Expert Opin. Drug Discov. 2012, 7, 99–107.
6. T. C. Le, D. A. Winkler, ChemMedChem 2015, 10, 1296–1300;
7. G. Schneider, M. Hartenfeller, M. Reutlinger, Y. Tanrikulu, E. Proschak, P. Schneider, Trends Biotechnol. 2009, 27, 18–26.
8. A. A. Toropov, A. P. Toropova, I. Raska Jr, D. Leszczynska, J. Leszczynski, Comput. Biol. Med. 2014, 45, 20–25;
9. J. L. McDonagh, N. Nath, L. De Ferrari, T. van Mourik, J. B. Mitchell, J. Chem. Inf. Model. 2014, 54, 844–856.
10. T. Fujita, D. A. Winkler, J. Chem. Inf. Model. 2016, 56, 269–274;
11. T. Wang, M. B. Wu, J. P. Lin, L. R. Yang, Expert Opin. Drug Discov. 2015, 10, 1283–1300;
12. Danishuddin, A. U. Khan, Drug Discovery Today 2016, 21, 1291–1302.
13. P. Willett, Mol. Inf. 2014, 33, 403–413.
14. A. B. Raies, V. B. Bajic, Wiley Interdiscip. Rev. Comput. Mol. Sci. 2016, 6, 147–172;
15. J. Kirchmair, A. H. Göller, D. Lang, J. Kunze, B. Testa, I. D. Wilson, R. D. Glen, G. Schneider, Nat. Rev. Drug Discov. 2015, 14, 387–404;
16. V. G. Maltarollo, J. C. Gertrudes, P. R. Oliveira, K. M. Honorio, Expert Opin. Drug Metab. Toxicol. 2015, 11, 259–271;
17. P. Schneider, M. Röthlisberger, D. Reker, G. Schneider, Chem. Commun. 2016, 52, 1135–1138.
18. J. C. Wang, J. H. Lin, Curr. Pharm. Des. 2013, 19, 2174–2182;
19. Q. U. Ain, A. Aleksandrova, F. D. Roessler, P. J. Ballester, Wiley Interdiscip. Rev. Comput. Mol. Sci. 2015, 5, 405–424;
20. M. R. Reddy, C. R. Reddy, R. S. Rathore, M. D. Erion, P. Aparoy, R. N. Reddy, P. Reddanna, Curr. Pharm. Des. 2014, 20, 3323–3337.
21. E. Gawehn, J. A. Hiss, G. Schneider, Mol. Inf. 2016, 35, 3–14.